China's Clover applies for Philippines COVID-19 vaccine trial - (MSN via NewsPoints Desk)

  • Clover Biopharmaceuticals is seeking to conduct late-stage clinical trials in the Philippines of its coronavirus vaccine, as reported by MSN.

  • The company is the second Chinese developer to apply for Phase III trials in the Philippines following Sinovac Biotech, which is looking to start trials of its vaccine as early as next month.

  • The Philippines is also evaluating COVID-19 vaccines under development by Johnson & Johnson and Russia's Gamaleya Research Institute for late-stage trials.

To read more NewsPoints articles, click here.